InvestorsHub Logo
Followers 4
Posts 398
Boards Moderated 0
Alias Born 06/21/2006

Re: maumar post# 3529

Saturday, 10/04/2014 2:36:55 PM

Saturday, October 04, 2014 2:36:55 PM

Post# of 8493
Yes. IMO, that is one reason the big open market buys from the CEO and CFO are so important.

But I think it is still kind of early to see real separation between cohorts. So, efficacy data would be suspect. I do think, perhaps, they could present some of the run-in safety stuff. It was designed to be separate and might allow them an easy analysis. For instance, he could say that there was no problem with the new formulation and let us know it is being used in the larger part of the study.

My expectations are low but my fingers are crossed for more.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News